Your Search Returned 5 tagged news reports
failed attempt to get its blood thinner Xarelto approved by the FDA for a lucrative new treatment area. In this video, Brenton tells us about one headwind that could potentially impact sales of blood thinners across the board. BSX ) to prevent
Tags:
announcement last week that it will purchase AssuraMed. Brenton tells investors that he was particularly unsurprised by this deal, based on a growing trend of mailing medical supplies directly to the home. In this video, Brenton discusses why this
Tags:
With the stock still down around 80% from its highs less than a decade ago, there's been no giant leap for MannKind shareholders. The debate rages over whether the company's revolutionary inhalable insulin, slated to go in front of the FDA next year,
Tags:
In today's video, our health-care analysts discuss the the impending spinoff of Abbott Labs ' branded-drug business. It's a confusing event to understand, with many investors left wondering what to do with these two stocks once they're separated. To
Tags:
However, Brenton sees Amazon as a much more compelling long-term story than Apple, which will have to continually innovate each and every year to stay relevant in the rapidly evolving consumer-electronics industry. Follow along for a summary of
Tags: